Skip to content

Credit up to CHF 99.–

How hair loss happens

Hereditary hair loss is the most common form in men. It starts in the hair follicle, long before you see it.

Start consultation

The medical assessment costs CHF 99.–. If nothing is prescribed, you get the full amount back.

More than4 in 10

men aged 18 to 49 have noticeable hereditary hair loss.1Among 18- to 29-year-olds, it is already about one in six.1Rhodes et al., Dermatol Surg 1998

What happens in the hair follicle

Hereditary hair loss does not happen overnight. It progresses in small steps.

  1. The follicle reacts

    In many men, the follicles on the forehead, temples and crown are hereditarily sensitive to the hormone DHT, while those at the back of the head usually are not.

DHTDHTDHTDHT
DHTDHTDHTDHT
  1. The hair gets finer

    The follicle gets smaller from cycle to cycle. The hair grows back thinner and shorter.

DHTDHTDHTDHT
DHTDHTDHTDHT
  1. The pauses get longer

    The growth phase gets shorter, the resting phase longer, and some follicles stay empty for a while. That is how hair gradually looks thinner.

DHTDHTDHTDHT
DHTDHTDHTDHT

The hair cycle

Every hair follicle alternates between long growth phases and short breaks.

85%growing
Share of hairs per phase, schematic.
  • Growth (Anagen), usually several years

    The follicle forms the hair, on average for almost four years. About 85 in 100 hairs are in this phase.2

  • Transition (Catagen), short

    The follicle stops growing. Only a few hairs are in this phase at any time.2

  • Rest (Telogen), about 4 months

    About 15 in 100 hairs are resting. A new hair grows underneath and pushes the old one out.2

Recognising patterns

Hereditary hair loss usually shows at the forehead, temples or crown, rarely at the back of the head.

A pattern is a hint, not a diagnosis. A doctor assesses what it means for you based on photos.

Causes and types of hair loss

What research shows

  1. Miniaturisation, step by step

    In hereditary hair loss, affected follicles gradually get smaller, which experts call miniaturisation.3 Strong hairs become thinner and shorter, and in the end fine, downy hairs.4

    At the same time, the number of active follicles goes down.3 It mainly affects the forehead, temples and crown, while the back of the head is usually spared.3

  2. Genes and DHT work together

    What matters is a hereditary predisposition together with male hormones in the blood.5 Inside the follicle itself, an enzyme converts testosterone into DHT.6

    Through hormone receptors, DHT changes signalling substances there that keep hair growing.37 Many genes are involved, and more than 380 regions of the genome are known today.36

  3. Longer rest, empty follicles

    Healthy follicles have long growth phases and short rest phases.5 In hereditary hair loss this reverses, the growth phase gets shorter and the rest phase longer.5

    After shedding, the follicle also stays empty more often and for longer before a new hair grows. Experts call this phase kenogen.84 So fewer hairs are growing at the same time, and the hair looks thinner.38

  4. Biotin and other supplements are poorly supported

    Biotin can help with a biotin deficiency and some rare hair and nail conditions, both of which are uncommon.9 There is not enough evidence that it works against hereditary hair loss in healthy people.9

    Some other products have positive studies, but they are often small and vary in quality.1011 High-dose biotin can also distort some lab results.12

Which active ingredients exist and how they have been studied is covered in the overview of active ingredients.

Active ingredients at a glance

Sources

Every source is checked on PubMed and linked. Last updated October 27, 2026

How we create content
  1. Rhodes T, Girman CJ, Savin RC, et al. Prevalence of male pattern hair loss in 18–49 year old men. Dermatol Surg. 1998;24(12):1330–1332. Norwood III or higher: 42% at 18–49, 16% at 18–29, 53% at 40–49. doi:10.1111/j.1524-4725.1998.tb00009.x (opens in a new tab)
  2. Hughes EC, Syed HA, Saleh D. Telogen Effluvium. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated 2024 May 1. PMID 28613598 (opens in a new tab)
  3. Liu Y, Tosti A, Wang ECE, et al. Androgenetic alopecia. Nat Rev Dis Primers. 2025;11(1):73. doi:10.1038/s41572-025-00656-9 (opens in a new tab)
  4. Whiting DA. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss. J Am Acad Dermatol. 2001;45(3 Suppl):S81–S86. doi:10.1067/mjd.2001.117428 (opens in a new tab)
  5. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med. 2002;4(22):1–11. doi:10.1017/S1462399402005112 (opens in a new tab)
  6. Hoffmann R, Happle R. Current understanding of androgenetic alopecia. Part I: etiopathogenesis. Eur J Dermatol. 2000;10(4):319–327. PMID 10846263 (opens in a new tab)
  7. Inui S, Itami S. Androgen actions on the human hair follicle: perspectives. Exp Dermatol. 2013;22(3):168–171. doi:10.1111/exd.12024 (opens in a new tab)
  8. Rebora A, Guarrera M. Kenogen. A new phase of the hair cycle?. Dermatology. 2002;205(2):108–110. doi:10.1159/000063908 (opens in a new tab)
  9. Patel DP, Swink SM, Castelo-Soccio L. A Review of the Use of Biotin for Hair Loss. Skin Appendage Disord. 2017;3(3):166–169. doi:10.1159/000462981 (opens in a new tab)
  10. Drake L, Reyes-Hadsall S, Martinez J, et al. Evaluation of the Safety and Effectiveness of Nutritional Supplements for Treating Hair Loss: A Systematic Review. JAMA Dermatol. 2023;159(1):79–86. doi:10.1001/jamadermatol.2022.4867 (opens in a new tab)
  11. Zhou L, Zhu W, Chen Y. Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis. Front Nutr. 2025;12:1719711. doi:10.3389/fnut.2025.1719711 (opens in a new tab)
  12. Li D, Radulescu A, Shrestha RT, et al. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults. JAMA. 2017;318(12):1150–1160. doi:10.1001/jama.2017.13705 (opens in a new tab)

Five minutes today.A medical decision usually within 1 to 2 business days.